| 摘要 |
The present invention relates to a pharmaceutical composition for regenerating liver damage caused by HBV infection and, more specifically, to a pharmaceutical composition for regenerating liver damage caused by HVB infection which comprises antibodies or siRNA for DNA methyltransferase 3A2 as active ingredients. |
